Ep190: Neil Kumar on Building a Rare Disease Drug Company
The Long Run with Luke Timmerman
00:00
BridgeBio's hub-and-spoke model explained
Neil explains the hub-and-spoke structure: asset selection, centralized infrastructure, and focused disease teams.
Play episode from 20:03
Transcript
